Ai In Healthcare

Telehealth "digital waiting rooms" are turning into premium pharma ad slots

New patient-attention data and agency execution details are pushing pharma media plans toward pre- and post-visit virtual care moments.

Cancer diagnostics growth is forcing labs to budget for data, not just instruments

MarketsandMarkets forecasts cancer diagnostics will grow from $29.86B in 2026 to $44.92B by 2031. Frost & Sullivan says the constraint is operational: staffing,

Quotient Sciences launches Phase I study of what it calls the first AI-formulated drug in the clinic

Quotient Sciences initiates what it calls the first Phase I trial of an AI-designed oral drug formulation, approved by the UK's MHRA.

Quotient Sciences launches Phase I trial of what it calls the first AI-formulated drug to reach the clinic

Quotient Sciences has initiated a Phase I study of an AI-designed oral formulation, cleared by the MHRA, marking a concrete shift from AI experimentation to clin

AI-Driven Amino Acid Drugs Surface as a Promising Treatment for Eye Conditions

The rapid evolution of artificial intelligence (AI) promises to revolutionize multiple sectors, and one area seeing tangible benefits is drug development. Historically, the creation of new medicines was a time-consuming endeavor, but AI-driven amino acid research is proving to accelerate the early developmental stages and get drugs to the market faster. Researchers at the Wilmer…

Leaders Driving Change at SXSW: Part One

Learning about and experimenting with new products is what makes attending an event like SXSW an enjoyable and worthwhile endeavor. Hearing specific stories of how these developments have already saved lives and changed the world elevates the SXSW experience from one of intrigue to captivation. MarketScale conversed with 10 SXSW speakers about their new…